trending Market Intelligence /marketintelligence/en/news-insights/trending/cdrmPnpI-mDPB6IfBHTKXA2 content esgSubNav
In This List

Clinuvel Pharmaceuticals board member to retire

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Clinuvel Pharmaceuticals board member to retire

Clinuvel Pharmaceuticals Ltd said Elie Ishag will not stand for re-election as a nonexecutive director at the company's 2017 annual general meeting.

Ishag, who has been on the board since February 2011, will continue to serve until the date of the meeting.

Clinuvel said it is searching for a new director.